Abstract ID: 79 Histopathologic Endpoints in Children With Eosinophilic Esophagitis Improved With Dupilumab Treatment: Results From Week 52 of the Phase 3 EOE Kids Trial
Restricted accessAbstractFirst published online September, 2024
Abstract ID: 79 Histopathologic Endpoints in Children With Eosinophilic Esophagitis Improved With Dupilumab Treatment: Results From Week 52 of the Phase 3 EOE Kids Trial